Skip to content
PMPMedium

PMP Practice: Determine Threats to Compliance

Question 2 of 6 in Plan and Manage Project Compliance

Pick an answer below — you'll get the explanation instantly, no signup.

Tomáš Kovář-Novotný is managing a pharmaceutical packaging automation project for Sisu Aerospace. The project involves installing robotic systems in a facility that must comply with FDA Good Manufacturing Practice (GMP) regulations. During the construction phase, the compliance officer discovers that three equipment vendors have provided certificates of conformance, but the project's quality assurance plan only requires verification testing for equipment critical to product sterility—not for the robotic packaging line components. The compliance officer warns that recent FDA guidance now recommends validation testing for all automated systems that interface with regulated products, even packaging. The project baseline includes validation for sterility equipment only, and adding comprehensive robotic validation would require an additional four weeks and $180,000. The project sponsor emphasizes staying on schedule to meet a product launch date tied to a major customer contract. Which approach would be MOST effective for measuring compliance in this situation?
Show answer & explanation

Correct answer: Conduct a compliance gap analysis comparing current project plans against the new FDA guidance, document findings with associated risks and costs, and present options to the change control board

Explanation

In a regulated environment, measuring compliance requires systematic assessment when new guidance emerges, even mid-project. The gap analysis approach allows the project manager to objectively measure the extent of compliance with evolving standards, quantify the impact of addressing gaps versus accepting residual risk, and enable informed decision-making by governance authorities. This approach fulfills the PM's responsibility to provide complete information to decision-makers while respecting the sponsor's authority over scope and schedule trade-offs. The compliance officer has raised a legitimate concern about industry guidance that could affect inspection outcomes, and the sponsor needs clear data on options and consequences—not a unilateral PM decision. The gap analysis documents the current state versus recommended practice, preserves traceability for audits, and allows the organization to make a risk-informed choice about how to proceed.

**Why not B:** This approach fails to recognize that compliance is a continuous measurement activity, not a one-time baseline check. Regulatory environments evolve, and project managers in regulated industries have a responsibility to assess emerging guidance against current plans. Deferring this to 'lessons learned' ignores an active compliance concern during project execution and could expose the organization to regulatory risk. While the baseline was valid at initiation, measuring ongoing compliance requires reassessment when circumstances change.

**Why not C:** This approach misunderstands the nature of regulatory compliance measurement. While FDA guidance documents are not legally binding regulations, they represent the agency's current thinking on acceptable practices and are routinely used as inspection criteria. Waiting for written confirmation of a violation before measuring compliance is reactive rather than proactive. The project manager's role is to assess the gap between current plans and recommended practice, not to negotiate the definition of compliance with the compliance officer or wait for a violation to materialize.

**Why not D:** This approach makes a unilateral decision that exceeds the project manager's authority regarding scope and schedule changes. While compliance is critical, the PM does not have the authority to independently add $180,000 in costs and delay a customer-tied launch date—these are governance-level decisions. The sponsor may choose to accept the risk after understanding the implications, pursue alternative mitigation strategies, or approve the change. The PM's role is to measure and present the compliance gap with options, not to mandate the solution.

Key Concept

This question covers Determine Threats to Compliance under Plan and Manage Project Compliance (Business Environment).

Share:

This is 1 of 100 free PMP questions

Unlock 6,300+ PMP practice questions with detailed explanations, progress tracking, and exam readiness prediction.

Unlock All Questions